Search
forResearch 10 of 1000+
- Biofibre hair implant: what is new, what is true?
- Scale-Up of a Medicinal and Aromatic Plant-Based Shampoo Formulation: Physicochemical Quality, Microbiological Safety, and Stability Analyses
- Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine
- Concept Paper on Health and Safety Issues in Day Care. Final Manuscript.
- Comparative Analysis of Labeling and Claim Substantiation Requirements for Herbal Hair Products across Different Regulatory Jurisdictions
- From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries
- Hair Care Cosmetics Regulation in Different Countries – A Comparative Study
- Kollaboratív robotok ipari alkalmazása
- Warfarin: almost 60 years old and still causing problems
- Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010
Community 10 of 282
- PP405 2a study was a safety study. Some rational explaining.
- Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
- Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study
- Kintor long term safety phase 3
- Effectiveness and Safety of Hair Growth Formulation Containing Tectona grandis L.f (Teak) Leaf Extract
- KX-826: Long-Term Safety Results are out!
- 2.5mg dut safety/price/synergy w/topical fin
- How can I safely apply RU58841 whilst I have children in the house?
- How to safely stop topical finasteride?
- Study: You can safely conceive on Dutasteride
Learn
— no results
Try a deeper search in learn →